Viz.ai Partners with Wolters Kluwer Health to Add UpToDate Resource to its Platform
Health systems are jumping to integrate AI into clinicians' everyday tools. When those platforms also offer the medical evidence that healthcare providers need to make on-the-fly clinical decisions, patient care can improve. Viz.ai and Wolters Kluwer Health are partnering to do just that.
Marrow Therapeutics Unveils $173M for ‘Trojan Horse’ Delivery of Blood Disorder Drugs
Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both blood disorders, Marrow executives say manufacturing and dosing advantages could make their medicine more broadly accessible across the world.
Your AI Vendor’s Medical Exam Score Doesn’t Mean What You Think It Does
If health systems want to adopt AI at scale, they need evaluation that is open, reproducible, and continuously updated. That’s also much harder to build in healthcare than in general-purpose AI, for these 3 reasons.
The BCI Race Everyone is Watching May Be the Wrong One
The technology race gets the attention. Another race may determine what becomes the new standard of care.
Medicare Pays For the AI Eye Scan — Nobody Pays For What Comes Next
Payment isn’t the only barrier, but it shapes all the others.